Symbols / AMAM
AMAM Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- How this Taiwanese hospital enhances supply chain management with advanced analytics - Healthcare IT News Mon, 02 Jun 2025 07
- Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J - Yahoo Finance ue, 09 Jan 2024 08
- (AMAM) Ambrx Holders Who Bought for Pennies See 6,700% Gain on J&J Bid - Bloomberg ue, 09 Jan 2024 08
- Johnson & Johnson Pays $2 Billion for Ambrx To Boost Its Cancer Drug Pipeline - Investopedia Mon, 08 Jan 2024 08
- J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion - CNBC Mon, 08 Jan 2024 08
- 2023 gainers and losers: Positive trial outcomes and M&As propel biopharma stocks to strong finish - BioWorld MedTech ue, 23 Jan 2024 08
- J&J Buys Up Ambrx for $2B - San Diego Business Journal Mon, 15 Jan 2024 08
- 7 Cheap Stocks That Are Worth Your Attention - Nasdaq Mon, 03 Apr 2023 07
- Biggest stock movers today: Boeing, American Eagle Outfitters, Harpoon Therapeutics, Ambrx, and more - Seeking Alpha Mon, 08 Jan 2024 08
- Meet the Biotech Stock That Jumped Over 1000% in One Day - Yahoo Finance Sun, 11 Dec 2022 08
- Why Shares of Ambrx Biopharma Soared This Week - The Motley Fool hu, 21 Sep 2023 07
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy - Entrepreneur ue, 07 Mar 2023 08
- Ambrx Announces Sale to Johnson & Johnson - GlobeNewswire Mon, 08 Jan 2024 08
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace Fri, 17 Feb 2023 08
- 3 Stocks to Buy That Are Up 200% or More in 2024 - Yahoo Finance Fri, 23 Feb 2024 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AMAM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|